K M C Speciality Hospitals (India) Limited

K M C Speciality Hospitals (India) Limited (KMCSHIL) is a micro-cap Healthcare company valued at ₹2,556 crore operating in Hospital on the NSE and BSE.

Recent price move

K M C Speciality Hospitals (India) Limited last traded at ₹156.1, down 3.40% on the day.

Recent developments

2026-09-30: Promoter holding remained at 75.00%, indicating no change in ownership structure. 2026-06-30: The latest quarter reported revenue of ₹92 crore and net profit of ₹17 crore, showing strong growth compared to the same quarter a year earlier. 2026-03-31: The company ended the fiscal year with revenue of ₹306 crore and net profit of ₹47 crore, reflecting continued expansion and profitability.

Financial performance

The company's business is improving, with annual revenue rising 32.0% and annual net profit surging 118.1%. The latest quarter saw revenue and net profit both jump significantly, with revenue up 37.9% and net profit up 119.8% compared to the same quarter a year earlier. Net profit margin has widened to 15.3% from 9.3% a year ago, while return on equity and return on capital employed remain strong at 22.2% and 24.3%, respectively.

Valuation multiples

The stock trades at 54.4 times earnings, a premium to the Healthcare median of 32.0, 10.63 times book value.

Things to watch

The stock is 12.8% below its 52-week high, which may indicate a pullback from recent peak levels. While the company has shown strong growth in both revenue and net profit, the market cap of ₹2,635 crore places it in the micro-cap category, which can be more volatile. The company's debt to equity ratio of 0.40 suggests moderate leverage, but this could become a concern if interest rates rise.

Where it stands

The company has delivered robust growth in both revenue and net profit over the past year and quarter, with net profit margin expanding significantly. The stock is currently trading 12.8% below its 52-week high, but the company's strong financials and growth rates suggest a solid foundation. The most significant figure is the latest quarter net profit of ₹17 crore, reflecting continued improvement in the business.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.